201
Published 2019
Canadian Agency for Drugs and Technologies in Health
... of both eyes. The manufacturer submitted a cost-utility analysis comparing LBN with currently available...

202
Published 2023
Springer Nature Singapore
... information on clinical utility, and possible side effects associated with the use of these pharmaceutical...

203
by Swift, Elaine K.
Published 2002
National Academies Press
Table of Contents: ... care -- Measuring disparities in health care quality and service utilization -- Measuring disparities...

204
by Du, Fenglian, Wang, Wenbin, Dong, Xiaoyuan
Published 2023
Springer Nature Singapore
Table of Contents: ... of Time Utilization of School-age Children -- Chapter 2. Equity in Education from the Perspective...

205
by Wright, H.G.
Published 2007
Springer Netherlands
Table of Contents: ..., Utility and Value in Means and Ends Reasoning -- Full Spectrum Means and Ends Reasoning...

206
by Grossmann, Claudia
Published 2011
National Academies Press
Table of Contents: ...Introduction -- Visioning perspectives on the digital health utility -- Technical issues...

207
by Evans, Steven
Published 1997
Springer New York
Table of Contents: .... Issues in Semantic Network Development and Utilization -- 7. Synthesis of Principles and Lessons Learned...

208
by Wolbarsht, Myron
Published 1977
Springer US
Table of Contents: ... Interferometry in a Laboratory Installation Utilizing a CW Laser -- 4. Hologram Interferometry In Vivo Utilizing...

209
Published 2003
Springer New York
Table of Contents: ... Systems -- Important Medical Coding Systems -- Typical Medical Documentation -- Utilization of Clinical...

210
by Williams, Gareth R.
Published 2018
UCL Press
... in the field the utility of nanofibres in drug delivery, and to explain to them how to prepare fibres...

211
Published 2019
Canadian Agency for Drugs and Technologies in Health
... of both eyes. The manufacturer submitted a cost-utility analysis comparing LBN with currently available...

212
Published 2008
National Academies Press
... an independent assessment (with emphasis on the work done by the IPTi consortium) of the utility, safety...

213
Published 2019
Canadian Agency for Drugs and Technologies in Health
... to withdraw the submission during the review period. The manufacturer submitted a cost-utility analysis (CUA...

214
by Pray, Leslie A.
Published 2017
the National Academies Press
Table of Contents: ... forward -- Health aging: what is it? are there acceptable markers to utilize in developing strategies...

215
by Hardey, Michael, Mulhall, Anne
Published 1994
Springer US
Table of Contents: ... and utilization of nursing research -- Appendix: tables of further information -- References...

216
Published 2023
OECD Publishing
Table of Contents: ...Recursos útiles -- Prólogo -- Planificar, implementar y evaluar un proceso de participación...

217
Published 2020
Canadian Agency for Drugs and Technologies in Health
...-utility analysis (CUA) comparing erenumab to best supportive care (BSC) for both the indicated population...

218
Published 2019
Canadian Agency for Drugs and Technologies in Health
... to withdraw the submission during the review period. The manufacturer submitted a cost-utility analysis (CUA...

219
Published 2019
Canadian Agency for Drugs and Technologies in Health
... submitted a cost-utility analysis of patisiran compared with inotersen in its base case and compared...

220
Published 2019
Canadian Agency for Drugs and Technologies in Health
... cost-utility analysis over a 40-year time horizon (the manufacturer suggests that this is essentially a...